39
https://pubmed.ncbi.nlm.nih.gov/38093257
Early stages of Alzheimer’s disease are characterized by glial hypo- and hyperactivation, with immune hypoactivation accompanying amyloidosis and activation with increased fractalkine levels associated with tau pathology.
